Cipla Q4 Results: Stock gains after US sales, ex-impairment margins meet expectations

During the quarter, Cipla had recorded an impairment of ₹42.02 crore with regards to associates, due to charges in certain business conditions and market dynamics.

Leave a Reply

Your email address will not be published. Required fields are marked *